Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

AIDAN HOLLIS

Biographic Data

ID5739558
NAMEAIDAN HOLLIS
GIVEN NAMESAIDAN
FAMILY NAMEHOLLIS
SIGNATUREHOLLIS A
AFFILIATIONSUniversity of Calgary
ORCID0000-0001-5125-2193
VERIFIEDYes
TOTAL WORKS13
TOTAL CITATIONS36
WORKS AS AUTHOR13
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1998
LATEST PUBLICATION YEAR2025
H-INDEX3
  • Armed conflict and child vaccination in Nigeria

    Open Access•Dongqin Wang, AIDAN HOLLIS et al.•ARTICLE•BMJ Global Health•2025

    This study investigates how armed conflict influenced paediatric vaccination uptake in Nigeria. Combining Demographic and Health Survey data with detailed conflict event information, we examine the relationship between the intensity of reported conflicts near children’s residences and their vaccination probabilities. Our findings reveal that a 1 SD increase in conflict intensity reduced vaccination rates by 0.73–1.80 percentage points (between 2.…

  • The impact of changing the reference countries on the list prices for patented medicines in Canada

    Open Access•Wei Zhang, Daphne Guh et al.•ARTICLE•Health Policy•2024

    BACKGROUND: Canada's Patented Medicine Prices Review Board (PMPRB) uses external and internal reference pricing (IRP) to regulate patented drug list prices. PMPRB has changed external reference countries from 7 to 11 to include countries with prices closer to the OECD median. We examined the impact on the list prices for patented medicines had the amendment been implemented from 2013. METHODS: Using IQVIA MIDAS® quarterly sales data, we selected …

  • Pull me – push you? The disparate financing mechanisms of drug research in global health

    Open Access•Max Alexander Matthey, AIDAN HOLLIS•ARTICLE•Globalization and Health•2024

    BACKGROUND: There is an inconsistency in the way pharmaceutical research is financed. While pull mechanisms are predominantly used to incentivize later-stage pharmaceutical research for products with demand in the Global North, so-called neglected diseases are chiefly financed by push funding. This discrepancy has so far been ignored in the academic debate, and any compelling explanation for why we draw the line between push and pull at poor peop…

  • The effect of antibiotic usage on resistance in humans and food-producing animals

    Open Access•Sakib Rahman, AIDAN HOLLIS•ARTICLE•Frontiers in Public Health•2023

    This paper estimates the effect of antibiotic usage in humans and food-producing animals on the prevalence of resistance in zoonotic bacteria in both humans and animals. Using comprehensive longitudinal data from annual surveillance reports on resistance and usage in Europe, we find that antibiotic usage in food-producing animals and antibiotic usage in humans are independently and causally related to the prevalence of resistance in both humans a…

  • Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada

    Open Access•Kayley D McCubbin, R Michele Anholt et al.•ARTICLE•Frontiers in Public Health•2021

    Current limitations in the understanding and control of antimicrobial resistance (AMR) in Canada are described through a comprehensive review focusing on: (1) treatment optimization; (2) surveillance of antimicrobial use and AMR; and (3) prevention of transmission of AMR. Without addressing gaps in identified areas, sustained progress in AMR mitigation is unlikely. Expert opinions and perspectives contributed to prioritizing identified gaps. Usin…

  • Attitudes, behaviours and barriers to public health measures for Covid-19

    Open Access•Raynell Lang, Jamie L Benham et al.•ARTICLE•BMC Public Health•2021

    These results suggest informational frames and themes focusing on individual risks, highlighting concern for COVID-19 and targeting improving trust for health authorities may be most effective in increasing public health measures. With the ultimate goal of preventing spread of COVID-19, understanding persons' attitudes towards both public health measures and a COVID-19 vaccine remains critical to addressing barriers and implementing targeted inte…

  • P1-9 The health impact fund-meeting the challenge of health impact assessment

    Amitava Banerjee, AIDAN HOLLIS et al.•ARTICLE•Journal of Epidemiology and…•2011

    Introduction The Health Impact Fund (HIF) is a publicly funded international agency proposed to enable pharmaceutical innovators to register a product for health impact rewards in exchange for selling it worldwide at cost. Supplementing the current patent regime, the HIF would improve incentives to research diseases concentrated among the poor. A workable HIF presupposes a consistent, predictable, and contractible method of health impact assessme…

  • The Role of Local Depositors in Controlling Expenses in Small‐Scale Financial Intermediation

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Economica•2007•Cited by: 1•References: 16

    Using data on Irish loan funds, a nineteenth‐century quasi‐bank system, we explore how the capital structure affects managerial agency to impact non‐interest expenses. These organizations had no equity‐holders and were financed by deposits and ‘capital’, comprising donations and accumulated profits, creating problems of managerial moral hazard. Higher net income (before non‐interest expenses) is associated with higher salaries and other non‐inter…

  • A National Formulary for Canada

    AIDAN HOLLIS, Stephen Law et al.•ARTICLE•Canadian Public Policy•2004

    This article analyzes the benefits and costs of replacing Canada's ten different provincial formularies with one single national formulary. The 2002 Romanow Commission on the Future of Health Care in Canada recommended that Canada should have a National Drug Agency which would maintain a national formulary, replacing the existing provincial formularies which balkanize drug markets across Canada. This recommendation has been in part incorporated i…

  • Microfinance and Famine

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•2004•Cited by: 4•References: 8

  • The Anti-Competitive Effects of Brand-Controlled "Pseudo-Generics" in the Canadian Pharmaceutical Market

    AIDAN HOLLIS•ARTICLE•Canadian Public Policy•2003

    Aidan Hollis, The Anti-Competitive Effects of Brand-Controlled "Pseudo-Generics" in the Canadian Pharmaceutical Market, Canadian Public Policy / Analyse de Politiques, Vol. 29, No. 1 (Mar., 2003), pp. 21-32

  • Microcredit

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•1998•Cited by: 23•References: 9

  • Microcredit in Prefamine Ireland

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Explorations in Economic History•1998•Cited by: 8•References: 15

  • Microcredit

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•1998•Cited by: 23•References: 9

  • Microcredit in Prefamine Ireland

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Explorations in Economic History•1998•Cited by: 8•References: 15

  • Microfinance and Famine

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•2004•Cited by: 4•References: 8

  • The Role of Local Depositors in Controlling Expenses in Small‐Scale Financial Intermediation

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Economica•2007•Cited by: 1•References: 16

    Using data on Irish loan funds, a nineteenth‐century quasi‐bank system, we explore how the capital structure affects managerial agency to impact non‐interest expenses. These organizations had no equity‐holders and were financed by deposits and ‘capital’, comprising donations and accumulated profits, creating problems of managerial moral hazard. Higher net income (before non‐interest expenses) is associated with higher salaries and other non‐inter…

  • Microcredit

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•1998•Cited by: 23•References: 9

  • Microcredit in Prefamine Ireland

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Explorations in Economic History•1998•Cited by: 8•References: 15

  • The Anti-Competitive Effects of Brand-Controlled "Pseudo-Generics" in the Canadian Pharmaceutical Market

    AIDAN HOLLIS•ARTICLE•Canadian Public Policy•2003

    Aidan Hollis, The Anti-Competitive Effects of Brand-Controlled "Pseudo-Generics" in the Canadian Pharmaceutical Market, Canadian Public Policy / Analyse de Politiques, Vol. 29, No. 1 (Mar., 2003), pp. 21-32

  • A National Formulary for Canada

    AIDAN HOLLIS, Stephen Law et al.•ARTICLE•Canadian Public Policy•2004

    This article analyzes the benefits and costs of replacing Canada's ten different provincial formularies with one single national formulary. The 2002 Romanow Commission on the Future of Health Care in Canada recommended that Canada should have a National Drug Agency which would maintain a national formulary, replacing the existing provincial formularies which balkanize drug markets across Canada. This recommendation has been in part incorporated i…

  • Microfinance and Famine

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•World Development•2004•Cited by: 4•References: 8

  • The Role of Local Depositors in Controlling Expenses in Small‐Scale Financial Intermediation

    Open Access•AIDAN HOLLIS, Arthur Sweetman•ARTICLE•Economica•2007•Cited by: 1•References: 16

    Using data on Irish loan funds, a nineteenth‐century quasi‐bank system, we explore how the capital structure affects managerial agency to impact non‐interest expenses. These organizations had no equity‐holders and were financed by deposits and ‘capital’, comprising donations and accumulated profits, creating problems of managerial moral hazard. Higher net income (before non‐interest expenses) is associated with higher salaries and other non‐inter…

  • P1-9 The health impact fund-meeting the challenge of health impact assessment

    Amitava Banerjee, AIDAN HOLLIS et al.•ARTICLE•Journal of Epidemiology and…•2011

    Introduction The Health Impact Fund (HIF) is a publicly funded international agency proposed to enable pharmaceutical innovators to register a product for health impact rewards in exchange for selling it worldwide at cost. Supplementing the current patent regime, the HIF would improve incentives to research diseases concentrated among the poor. A workable HIF presupposes a consistent, predictable, and contractible method of health impact assessme…

  • Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada

    Open Access•Kayley D McCubbin, R Michele Anholt et al.•ARTICLE•Frontiers in Public Health•2021

    Current limitations in the understanding and control of antimicrobial resistance (AMR) in Canada are described through a comprehensive review focusing on: (1) treatment optimization; (2) surveillance of antimicrobial use and AMR; and (3) prevention of transmission of AMR. Without addressing gaps in identified areas, sustained progress in AMR mitigation is unlikely. Expert opinions and perspectives contributed to prioritizing identified gaps. Usin…

  • Attitudes, behaviours and barriers to public health measures for Covid-19

    Open Access•Raynell Lang, Jamie L Benham et al.•ARTICLE•BMC Public Health•2021

    These results suggest informational frames and themes focusing on individual risks, highlighting concern for COVID-19 and targeting improving trust for health authorities may be most effective in increasing public health measures. With the ultimate goal of preventing spread of COVID-19, understanding persons' attitudes towards both public health measures and a COVID-19 vaccine remains critical to addressing barriers and implementing targeted inte…

  • The effect of antibiotic usage on resistance in humans and food-producing animals

    Open Access•Sakib Rahman, AIDAN HOLLIS•ARTICLE•Frontiers in Public Health•2023

    This paper estimates the effect of antibiotic usage in humans and food-producing animals on the prevalence of resistance in zoonotic bacteria in both humans and animals. Using comprehensive longitudinal data from annual surveillance reports on resistance and usage in Europe, we find that antibiotic usage in food-producing animals and antibiotic usage in humans are independently and causally related to the prevalence of resistance in both humans a…

  • The impact of changing the reference countries on the list prices for patented medicines in Canada

    Open Access•Wei Zhang, Daphne Guh et al.•ARTICLE•Health Policy•2024

    BACKGROUND: Canada's Patented Medicine Prices Review Board (PMPRB) uses external and internal reference pricing (IRP) to regulate patented drug list prices. PMPRB has changed external reference countries from 7 to 11 to include countries with prices closer to the OECD median. We examined the impact on the list prices for patented medicines had the amendment been implemented from 2013. METHODS: Using IQVIA MIDAS® quarterly sales data, we selected …

  • Pull me – push you? The disparate financing mechanisms of drug research in global health

    Open Access•Max Alexander Matthey, AIDAN HOLLIS•ARTICLE•Globalization and Health•2024

    BACKGROUND: There is an inconsistency in the way pharmaceutical research is financed. While pull mechanisms are predominantly used to incentivize later-stage pharmaceutical research for products with demand in the Global North, so-called neglected diseases are chiefly financed by push funding. This discrepancy has so far been ignored in the academic debate, and any compelling explanation for why we draw the line between push and pull at poor peop…

  • Armed conflict and child vaccination in Nigeria

    Open Access•Dongqin Wang, AIDAN HOLLIS et al.•ARTICLE•BMJ Global Health•2025

    This study investigates how armed conflict influenced paediatric vaccination uptake in Nigeria. Combining Demographic and Health Survey data with detailed conflict event information, we examine the relationship between the intensity of reported conflicts near children’s residences and their vaccination probabilities. Our findings reveal that a 1 SD increase in conflict intensity reduced vaccination rates by 0.73–1.80 percentage points (between 2.…

Business (7 works) · Medicine (7 works) · Economics (6 works) · Economic growth (5 works) · Pharmaceutical Economics and Policy (5 works) · Incentive (4 works) · Microfinance and Financial Inclusion (4 works) · Finance (3 works) · Financial system (3 works) · Health Systems, Economic Evaluations, Quality of Life (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae